Detalhe da pesquisa
1.
Phenotypic CD8 T cell profiling in chronic hepatitis B to predict HBV-specific CD8 T cell susceptibility to functional restoration in vitro.
Gut
; 72(11): 2123-2137, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36717219
2.
Deregulated intracellular pathways define novel molecular targets for HBV-specific CD8 T cell reconstitution in chronic hepatitis B.
J Hepatol
; 79(1): 50-60, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36893853
3.
Functional reconstitution of HBV-specific CD8 T cells by in vitro polyphenol treatment in chronic hepatitis B.
J Hepatol
; 74(4): 783-793, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33188902
4.
Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis.
Gastroenterology
; 157(1): 227-241.e7, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30930022
5.
TLR7 Agonist Increases Responses of Hepatitis B Virus-Specific T Cells and Natural Killer Cells in Patients With Chronic Hepatitis B Treated With Nucleos(T)Ide Analogues.
Gastroenterology
; 154(6): 1764-1777.e7, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29378197
6.
HBV Immune-Therapy: From Molecular Mechanisms to Clinical Applications.
Int J Mol Sci
; 20(11)2019 Jun 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31195619
7.
The Good and the Bad of Natural Killer Cells in Virus Control: Perspective for Anti-HBV Therapy.
Int J Mol Sci
; 20(20)2019 Oct 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-31614928
8.
Comment on 'End-of-treatment HBcrAg and HBsAb levels identify durable functional cure after Peg-IFN-based therapy in patients with CHB'.
J Hepatol
; 79(5): e202-e204, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37307998
9.
HBV antigens quantity: duration and effect on functional cure.
Gut
; 71(11): 2149-2151, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34799373
10.
Effector CD8+ T cell-derived interleukin-10 enhances acute liver immunopathology.
J Hepatol
; 67(3): 543-548, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28483675
11.
Natural killer cell phenotype modulation and natural killer/T-cell interplay in nucleos(t)ide analogue-treated hepatitis e antigen-negative patients with chronic hepatitis B.
Hepatology
; 62(6): 1697-709, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26361374
12.
PeptiVAX: A new adaptable peptides-delivery platform for development of CTL-based, SARS-CoV-2 vaccines.
Int J Biol Macromol
; 262(Pt 1): 129926, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38331062
13.
Increased levels of arginase in patients with acute hepatitis B suppress antiviral T cells.
Gastroenterology
; 143(1): 78-87.e3, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22475535
14.
Restored function of HBV-specific T cells after long-term effective therapy with nucleos(t)ide analogues.
Gastroenterology
; 143(4): 963-73.e9, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22796241
15.
The scientific basis of combination therapy for chronic hepatitis B functional cure.
Nat Rev Gastroenterol Hepatol
; 20(4): 238-253, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36631717
16.
High CD49a+ NK cell infiltrate is associated with poor clinical outcomes in Hepatocellular Carcinoma.
Heliyon
; 9(12): e22680, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38107324
17.
What Is the Current Status of Hepatitis B Virus Viro-Immunology?
Clin Liver Dis
; 27(4): 819-836, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37778772
18.
FluoroSpot assay to analyze SARS-CoV-2-specific T cell responses.
STAR Protoc
; 4(4): 102584, 2023 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37733600
19.
Natural heteroclitic-like peptides are generated by SARS-CoV-2 mutations.
iScience
; 26(6): 106940, 2023 Jun 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37275517
20.
T cell regulation in HBV-related chronic liver disease.
J Hepatol
; 66(5): 1096-1098, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28189261